News

US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is being ...
The blood test, branded as Lumipulse, will initially likely be used to rule out Alzheimer's, with positive results signaling the need for more advanced diagnostics. Alzheimer's, which gradually ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Wegovy maker’s share price halves amid rising pressure from Eli Lilly and compounded copycats Novo Nordisk has removed its long-serving CEO, Lars Fruergaard Jørgensen, as the Danish pharmaceutical ...
(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...